Camlin Fine Sciences Limited (CAMLINFINE.BO)
- Previous Close
109.37 - Open
110.01 - Bid 108.36 x --
- Ask 108.94 x --
- Day's Range
108.36 - 110.50 - 52 Week Range
88.45 - 186.25 - Volume
61,029 - Avg. Volume
132,855 - Market Cap (intraday)
18.195B - Beta (5Y Monthly) 0.99
- PE Ratio (TTM)
-- - EPS (TTM)
-0.23 - Earnings Date May 20, 2024 - May 24, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 28, 2016
- 1y Target Est
135.00
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; pharmaceutical and nutraceutical products from fermentation and plant extraction sources; and performance chemicals, such as hydroquinone and catechol. Its products are used in food and beverage, pet food and animal nutrition, rendering, aqua culture, petrochemical, pharmaceutical, agrochemical, dyes and pigment, biofuel, aroma technical, fragrance, and flavor industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
www.camlinfs.com627
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: CAMLINFINE.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CAMLINFINE.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CAMLINFINE.BO
Valuation Measures
Market Cap
18.20B
Enterprise Value
24.05B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.16
Price/Book (mrq)
1.93
Enterprise Value/Revenue
1.47
Enterprise Value/EBITDA
26.23
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.39%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
16.38B
Net Income Avi to Common (ttm)
-8.31M
Diluted EPS (ttm)
-0.23
Balance Sheet and Cash Flow
Total Cash (mrq)
1.01B
Total Debt/Equity (mrq)
73.51%
Levered Free Cash Flow (ttm)
--
Research Analysis: CAMLINFINE.BO
Company Insights: CAMLINFINE.BO
CAMLINFINE.BO does not have Company Insights